NeuroVentures Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 1
Professionals
  • Investments
  • 27
  • Portfolio
  • 3
  • Exits
  • 12
Exits

NeuroVentures Capital General Information

Description

Founded in 2000, NeuroVentures Capital is a venture capital firm that is based in Charlottesville, Virginia. It invests in companies that are involved in the discovery, development and marketing of new drugs, medical devices and other therapeutics and technologies to treat Central Nervous System disorders. It is based in Charlottesville, Virginia.

Contact Information

Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 427 Park Street
  • Charlottesville, VA 22902
  • United States

NeuroVentures Capital Investments (27)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
NanoMedical Systems 19-Dec-2013 Later Stage VC 00.000 Drug Delivery Generating Revenue
000000 0000000 000 25-Jun-2013 00000 00000 0000 Therapeutic Devices Generating Revenue
000000 00000000000 14-May-2013 00000 00000 0000 Drug Discovery Generating Revenue/Not Profitable 000000 0'0000000
0000000 09-Jan-2012 00000 00000 0000 Diagnostic Equipment Generating Revenue
00000000 000000 29-Sep-2010 00000000000 0000 Pharmaceuticals Generating Revenue
00000000 000000 29-Dec-2009 00000000000 00.00 Pharmaceuticals Generating Revenue
00000 000000000000 31-Oct-2008 00000 00000 0000 Drug Discovery Out of Business
0000000000 18-Apr-2008 00000 00000 000.00 Pharmaceuticals Out of Business
NeurAxon Pharma 20-Aug-2007 Early Stage VC 0000 Pharmaceuticals Generating Revenue
Setagon 02-Nov-2006 Bridge 00000 Drug Delivery Product Development 000000 0'0000000
You’re viewing 10 of 27 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroVentures Capital Exits (12)

Company Name Exit Date Exit Type Exit Size
Acumen Pharmaceuticals 01-Jul-2021 IPO 00000
0000000 01-Apr-2021 000000000 00000000
00000 000000000000 01-Jun-2016 000 00 00000000
00000000 000000 01-Jan-2015 000000000000000000 00.000
0000000000 01-Dec-2013 000 00 00000000
0000000000 0000000 03-Oct-2011 000000000000000000 00000
0000000 01-Nov-2007 000000000000000000 0000
000000 00000000000 26-Jun-2007 000000000000000000
Saegis Pharmaceuticals 12-Jan-2007 Merger/Acquisition
Scion Pharmaceuticals 17-Jun-2005 Merger/Acquisition
You’re viewing 10 of 12 exits. Get the full list »

NeuroVentures Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

NeuroVentures Capital Team (4)

Name Title Deals Funds Boards Office
Daniel O'Connell Managing Partner & Founding Member 0 0 0 Charlottesville, VA
James Murray Jr. Advisor 0 0 Charlottesville, VA
You’re viewing 2 of 4 team members. Get the full list »